- Home
- RDNT vs TERN Comparison
RDNT vs TERN Comparison
Compare RDNT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDNT | TERN |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.8B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RDNT | TERN |
|---|---|---|
| Price | $54.33 | $52.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $82.80 | $45.22 |
| AVG Volume (30 Days) | 787.6K | ★ 6.2M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,616,630,000.00 | N/A |
| Revenue This Year | $22.78 | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.05 | N/A |
| 52 Week Low | $50.79 | $3.55 |
| 52 Week High | $85.84 | $53.19 |
Technical Indicators
Market Signals| Indicator | RDNT | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 74.51 |
| Support Level | $51.97 | $52.42 |
| Resistance Level | $55.99 | $53.19 |
| Average True Range (ATR) | 2.17 | 0.07 |
| MACD | 0.05 | -0.31 |
| Stochastic Oscillator | 58.13 | 97.30 |
Price Performance
Historical ComparisonAbout RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.